Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby, Wei Shen Lim, Jonathan Emberson, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 8, pp. 693-704
Open Access | Times Cited: 7610

Showing 1-25 of 7610 citing articles:

Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 19, pp. 1813-1826
Open Access | Times Cited: 7135
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 141-154
Open Access | Times Cited: 4749
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, et al.
The Lancet (2021) Vol. 397, Iss. 10270, pp. 220-232
Open Access | Times Cited: 3956
Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Hongchao Pan, Richárd Pető, Ana‐Maria Henao‐Restrepo, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 6, pp. 497-511
Open Access | Times Cited: 2497
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang, et al.
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1636-1643
Open Access | Times Cited: 2278
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
Jonathan A C Sterne, Srinivas Murthy, Janet Dı́az, et al.
JAMA (2020) Vol. 324, Iss. 13, pp. 1330-1330
Open Access | Times Cited: 2140
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony Gordon, Paul Mouncey, Farah Al-Beidh, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 16, pp. 1491-1502
Open Access | Times Cited: 1733
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 3, pp. 238-251
Open Access | Times Cited: 1693
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 9, pp. 795-807
Open Access | Times Cited: 1681
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1419-1440.e23
Open Access | Times Cited: 1371
Genetic mechanisms of critical illness in COVID-19
Erola Pairo‐Castineira, Sara Clohisey, Lucija Klarić, et al.
Nature (2020) Vol. 591, Iss. 7848, pp. 92-98
Open Access | Times Cited: 1356
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen, Ajay Nirula, Barry N. Heller, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 3, pp. 229-237
Open Access | Times Cited: 1347
Cross Mark Policy

(2022)
Open Access | Times Cited: 1336
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 24, pp. 2333-2344
Open Access | Times Cited: 1311
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner, et al.
JAMA (2020) Vol. 324, Iss. 11, pp. 1048-1048
Open Access | Times Cited: 1177
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama, Jian Han, Linda Yau, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 1, pp. 20-30
Open Access | Times Cited: 1173
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
Bruno Martins Tomazini, Israel Silva Maia, Alexandre Biasi Cavalcanti, et al.
JAMA (2020) Vol. 324, Iss. 13, pp. 1307-1307
Open Access | Times Cited: 1157
Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
Barry M. Popkin, Shufa Du, William D. Green, et al.
Obesity Reviews (2020) Vol. 21, Iss. 11
Open Access | Times Cited: 1058
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10285, pp. 1637-1645
Open Access | Times Cited: 1016
A living WHO guideline on drugs for covid-19
Arnav Agarwal, Beverley J. Hunt, Miriam Stegemann, et al.
BMJ (2020), pp. m3379-m3379
Open Access | Times Cited: 962
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Iván O. Rosas, Norbert Bräu, Michael R. Waters, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 16, pp. 1503-1516
Open Access | Times Cited: 953
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, et al.
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1623-1635
Open Access | Times Cited: 919
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Ventura Simonovich, Leandro Daniel Burgos Pratx, Paula Scibona, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 7, pp. 619-629
Open Access | Times Cited: 908
Page 1 - Next Page

Scroll to top